Beth Jantzen - Mar 23, 2023 Form 4 Insider Report for APPLIED DNA SCIENCES INC (APDN)

Role
Chief Financial Officer
Signature
/s/ Beth Jantzen
Stock symbol
APDN
Transactions as of
Mar 23, 2023
Transactions value $
$0
Form type
4
Date filed
3/27/2023, 09:30 PM
Previous filing
Nov 3, 2021
Next filing
Oct 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APDN Common Stock Award $0 +91.7K +127315.28% $0.00 91.7K Mar 23, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APDN Incentive Stock Option (right to buy) Award $0 +98K $0.00 98K Mar 23, 2023 Common Stock 98K $1.08 Direct F2
transaction APDN Non-Qualified Stock Option (right to buy) Award $0 +1.96K $0.00 1.96K Mar 23, 2023 Common Stock 1.96K $1.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents common stock underlying restricted stock units granted to the reporting person on March 23, 2023. 100% of the restricted stock units vest upon the first anniversary of the grant date.
F2 The options vest 25% per year commencing on the first anniversary of the grant date.